Parasitaemia range | Malaria species | Therapy | Follow-up (parasitaemia reduction up to 0.001%) | |||
---|---|---|---|---|---|---|
24 h | 48 h | 72 h | > 72 h | |||
< 0.001–< 1% | 40 Pf | 12 Quininea | – | 1 | 1 | 1 |
8 Atovaquone + proguanil | – | – | 1 | – | ||
14 Mefloquine | – | 5 | 3 | 1 | ||
6 Piperaquine tetraphosphate + dihydroartemisinin | 1 | – | – | |||
2 Pv | 1 Chlorochine + primaquine | – | – | – | – | |
1 Chlorochine + ceftriaxone | – | – | – | – | ||
9 Po | 3 Mefloquine | – | 2 | – | – | |
1 Quinine | – | – | – | – | ||
1 Chlorochine + primaquine | – | – | – | – | ||
1 Quinine + doxycycline + primaquine | – | – | 1d | – | ||
1 Piperaquine tetraphosphate + dihydroartemisinin | – | – | – | – | ||
2 unknown | – | – | – | – | ||
1 Pm | 1 Atovaquone + proguanil | – | – | – | 1 | |
1 Pf + Po | 1 Atovaquone + proguanil + primaquine | – | – | – | – | |
1 Pf + Pm | 1 Piperaquine tetraphosphate + dihydroartemisinin | – | – | – | – | |
1–10% | 32 Pf | 15 Quinineb | – | 3 | 3 | 4 |
9 Mefloquine | – | 1 | – | 2 | ||
4 Atovaquone + proguanil | – | 1 | 2 | – | ||
4 Piperaquine tetraphosphate + dihydroartemisinin | – | 2 | – | – | ||
> 10% negative | 1 Pf | 1 Quinine | – | – | – | 1 |
2 Pf | 2 Untreatedc | – | – | – | – |